Season’s Greetings! As we reflect on the past year, I’d like to take a moment to sincerely thank you, our customers, partners, friends and families for your continued partnership and support. While changing external market dynamics continued to present new challenges and new opportunities – what did not change was our commitment to our mission.… Continue reading Happy Holidays from Glooko!
This month, Academy™, a free educational platform Glooko developed in conjunction with the Association of British Clinical Diabetologists (ABCD)/Diabetes Technology Network UK (DTN-UK) and DigiBete, launched a new training module on connected pens used by people with diabetes. This marks the eighth module on the CPD accredited platform for healthcare professionals in the U.K and… Continue reading Academy™ for U.K. and Ireland Healthcare Providers Adds Module to Further Training on Connected Pens Used by People with Diabetes
At Glooko, we believe being named a leader in CB Insights’ Diabetes Digital Therapeutics For Healthcare Payers — Execution & Market Strength Positioning (ESP) Vendor Matrix validates what our customers have been saying about our commitment to providing innovative digital health tools for chronic conditions like diabetes. Glooko was among the select companies that CB… Continue reading Glooko Named a Leader by Independent Research Firm in Diabetes Digital Therapeutics for Healthcare Payers
At Glooko, we’re committed to the security of personal data and protected health information. Through certifications from key global organizations, we’ve established both privacy protection and data security as critical, high-priority parts of our processes, practices and culture. We’re proud to announce that Glooko is now SOC 2 Type 1 certified. This comprehensive reporting standard… Continue reading Glooko Adds SOC 2 Type 1 Certification to its Growing Data Security and Privacy Accreditations
As of today, our real-world data repository at Glooko represents over five billion data points with 3.4 million users globally in over 7,500 clinics across 29 countries in 21 languages. The robust data points we gather that’s constantly growing each day include continuous blood glucose readings, insulin, exercise, food, medications, blood pressure, weight and patient… Continue reading Glooko’s Real-World Diabetes Patient Data Now Available on AWS Marketplace
At Glooko, we’re always innovating and expanding the features of our platform for people with diabetes and chronic conditions. Through user research, we’ve implemented a series of updates in Glooko Release 21.4 for professional and personal users. “In this release, we wanted to ensure patients using our digital health platform were having a more seamless… Continue reading Glooko Release 21.4 Brings Localized Unit of Measurement, Additional Data and Expanded Device Compatibility
To further our commitment to our community of patients with diabetes, clinical researchers and healthcare providers, Glooko is holding a Wellness Challenge for Team Glooko October 4 to 10, 2021, and we want you to get involved. Our Wellness Challenge, which leads up to the 30th anniversary of the American Diabetes Association’s virtual Tour de… Continue reading Join Glooko’s 2021 Wellness Challenge
Glooko is the leading diabetes data management and remote patient monitoring platform used by millions of people with diabetes and thousands of clinics worldwide. Our system has generated billions of real-world data points since 2005, enabling providers to analyze data from over 200 diabetes and biometric devices in a single location to improve patient care.… Continue reading Glooko’s Annual Diabetes Data Report – Remote patient monitoring and control trends during the COVID-19 pandemic